BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25667027)

  • 1. Symptomatic management for gastroparesis: antiemetics, analgesics, and symptom modulators.
    Hasler WL
    Gastroenterol Clin North Am; 2015 Mar; 44(1):113-26. PubMed ID: 25667027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroparesis-associated refractory nausea treated with aprepitant.
    Fahler J; Wall GC; Leman BI
    Ann Pharmacother; 2012 Dec; 46(12):e38. PubMed ID: 23191934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Gastroparesis Management: A United States Population-based Study From 2010 to 2020.
    Tanner SE; Kurin M; Shahsavari D; Malik Z; Parkman HP
    J Clin Gastroenterol; 2023 Sep; 57(8):789-797. PubMed ID: 36227007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.
    Simmons K; Parkman HP
    Dig Dis Sci; 2014 Jun; 59(6):1231-4. PubMed ID: 24615549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nausea and vomiting in advanced cancer.
    Ang SK; Shoemaker LK; Davis MP
    Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vomiting Patient: Small Bowel Obstruction, Cyclic Vomiting, and Gastroparesis.
    Nagarwala J; Dev S; Markin A
    Emerg Med Clin North Am; 2016 May; 34(2):271-91. PubMed ID: 27133244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of treatment for gastroparesis.
    Sarosiek I; Bashashati M; McCallum RW
    Expert Opin Drug Saf; 2016 Jul; 15(7):937-45. PubMed ID: 27031006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting.
    Hasler WL; Wilson LA; Parkman HP; Koch KL; Abell TL; Nguyen L; Pasricha PJ; Snape WJ; McCallum RW; Sarosiek I; Farrugia G; Calles J; Lee L; Tonascia J; Unalp-Arida A; Hamilton F
    Neurogastroenterol Motil; 2013 May; 25(5):427-38, e300-1. PubMed ID: 23414452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of gastroparesis.
    Reddymasu SC; McCallum RW
    Expert Opin Pharmacother; 2009 Feb; 10(3):469-84. PubMed ID: 19191682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis.
    Amin K; Bastani B
    Perit Dial Int; 2002; 22(4):539-40. PubMed ID: 12322834
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors.
    Anaparthy R; Pehlivanov N; Grady J; Yimei H; Pasricha PJ
    Dig Dis Sci; 2009 May; 54(5):1003-10. PubMed ID: 19277867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Controlled Double-blind Trial Comparing Haloperidol Combined With Conventional Therapy to Conventional Therapy Alone in Patients With Symptomatic Gastroparesis.
    Roldan CJ; Chambers KA; Paniagua L; Patel S; Cardenas-Turanzas M; Chathampally Y
    Acad Emerg Med; 2017 Nov; 24(11):1307-1314. PubMed ID: 28646590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine.
    Kundu S; Rogal S; Alam A; Levinthal DJ
    World J Gastroenterol; 2014 Jun; 20(21):6671-4. PubMed ID: 24914393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment.
    Kim SW; Shin IS; Kim JM; Kang HC; Mun JU; Yang SJ; Yoon JS
    Psychosomatics; 2006; 47(5):440-2. PubMed ID: 16959934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department.
    Ramirez R; Stalcup P; Croft B; Darracq MA
    Am J Emerg Med; 2017 Aug; 35(8):1118-1120. PubMed ID: 28320545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic gastroparesis.
    Parkman HP
    Gastroenterol Clin North Am; 2015 Mar; 44(1):59-68. PubMed ID: 25667023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relief of acute pain in chronic idiopathic gastroparesis with intravenous phentolamine.
    Phillips WJ; Tollefson B; Johnson A; Abell T; Lerant A
    Ann Pharmacother; 2006 Nov; 40(11):2032-6. PubMed ID: 17003080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain: the overlooked symptom in gastroparesis.
    Hoogerwerf WA; Pasricha PJ; Kalloo AN; Schuster MM
    Am J Gastroenterol; 1999 Apr; 94(4):1029-33. PubMed ID: 10201478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granisetron: an update on its clinical use in the management of nausea and vomiting.
    Aapro M
    Oncologist; 2004; 9(6):673-86. PubMed ID: 15561811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.